A Randomized Trial of Progesterone in Women with Recurrent Miscarriages
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Progesterone is essential for the maintenance of pregnancy. However, whether progesterone supplementation in the first trimester of pregnancy would increase the rate of live births among women with a history of unexplained recurrent miscarriages is uncertain. METHODS: We conducted a multicenter, double-blind, placebo-controlled, randomized trial to investigate whether treatment with progesterone would increase the rates of live births and newborn survival among women with unexplained recurrent miscarriage. We randomly assigned women with recurrent miscarriages to receive twice-daily vaginal suppositories containing either 400 mg of micronized progesterone or matched placebo from a time soon after a positive urinary pregnancy test (and no later than 6 weeks of gestation) through 12 weeks of gestation. The primary outcome was live birth after 24 weeks of gestation. RESULTS: A total of 1568 women were assessed for eligibility, and 836 of these women who conceived naturally within 1 year and remained willing to participate in the trial were randomly assigned to receive either progesterone (404 women) or placebo (432 women). The follow-up rate for the primary outcome was 98.8% (826 of 836 women). In an intention-to-treat analysis, the rate of live births was 65.8% (262 of 398 women) in the progesterone group and 63.3% (271 of 428 women) in the placebo group (relative rate, 1.04; 95% confidence interval [CI], 0.94 to 1.15; rate difference, 2.5 percentage points; 95% CI, -4.0 to 9.0). There were no significant between-group differences in the rate of adverse events. CONCLUSIONS: Progesterone therapy in the first trimester of pregnancy did not result in a significantly higher rate of live births among women with a history of unexplained recurrent miscarriages. (Funded by the United Kingdom National Institute of Health Research; PROMISE Current Controlled Trials number, ISRCTN92644181.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Caution should be exercised when interpreting the results of these meta-analyses due to differences in the RCTs included in the analyses.199,200”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [199]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kumar, A., Begum, N., Prasad, S., Aggarwal, S., & Sharma, S. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.07.1251 · Cited by 93
RetractedPeto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Evaluation and treatment of recurrent pregnancy loss: a committee opinion
(2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.048 · Cited by 1,308
Rai, R., & Regan, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69204-0 · Cited by 1,227
Self-citationProgesterone and the Risk of Preterm Birth among Women with a Short Cervix
Fonseca, E. B., Celik, E., Parra, M., Singh, M., & Nicolaides, K. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067815 · Cited by 1,086
da Fonseca, E. B., Bittar, R. E., Carvalho, M. H. B., & Zugaib, M. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.41 · Cited by 789
Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study
Stephenson, M. D. (2002) · Human Reproduction · doi:10.1093/humrep/17.2.446 · Cited by 522
A comparison of placental development and endocrine functions between the human and mouse model
Malassine, A., Frendo, J. L., & Evain-Brion, D. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg043 · Cited by 476
Targeted drug delivery in gynaecology: the first uterine pass effect
Bulletti, C., de Ziegler, D., Flamigni, C., Giacomucci, E., Polli, V., Bolelli, G., & Franceschetti, F. (1997) · Human Reproduction · doi:10.1093/humrep/12.5.1073 · Cited by 245
Progestogen for preventing miscarriage
Oates-Whitehead, R., Haas, D., & Carrier, J. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003511 · Cited by 224
Research works printed but not linked: 2
- Haas DM, 2013, Cochrane Database Syst Rev, 10, CD003511
- Levine L, 1964, West J Surg Obs Gynecol, 72, 30
Cited by
Items 201–300 of 309
Wu, J., LIU, X., HAN, L., Nie, H., Tang, Y., Tang, Y., Song, G., Zheng, L., & Qin, W. (2021) · Biocell · doi:10.32604/biocell.2022.016744 · Cited by 1
“Recurrent spontaneous abortion (RSA) refers to three or more consecutive spontaneous abortions before 20 weeks of pregnancy and affects approximately 1%–2% of couples who attempt to have a child (Coomarasamy et al., 2015; Raj and Lesley, 2006).”
BackgroundPeng, Y., Zhang, J., Lan, T., Liu, S., Ye, T., & Wang, Y. (2022) · Medicine · doi:10.1097/md.0000000000031885 · Cited by 1
Cutting, E., Abdallah, K. S., & Mol, B. W. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.103845 · Cited by 1
Self-citationThe in vitro mechanism of Vaspinregulates the proliferation and steroidogenesis of rat lutein cells
Fu, X.-W., Liu, L., Zhu, X., & Wang, J. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2351525 · Cited by 1
“Studies have shown that incomplete angiogenesis cannot guarantee the normal development of luteal cells, and it will affect the concentration of P4 in serum and result in abortion [40].”
Micronized progesterone use for miscarriage: discussion questions of clinical trials
Dubossarska, Y. O., & Дубоссарская, З. М. (2016) · Reproductive Endocrinology · doi:10.18370/2309-4117.2016.30.36-39 · Cited by 1
Reviewing efficacy of progestagenes in recurrent early reproductive losses
Veropotvelyan, N. P. (2016) · Reproductive Endocrinology · doi:10.18370/2309-4117.2016.31.22-33 · Cited by 1
“PROMISE (Progesterone in recurrent miscarriages) was the first randomized controlled study with the adequate statistical power where the frequency of live births was assessed as the primary endpoint [28].”
BackgroundMethodGenetic Screening and Early Recurrent Pregnancy Loss
Brezina, P. R. (2017) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-017-0207-1 · Cited by 1
Recurrent pregnancy loss-causes and management
Muthyala, T., & Rohilla, M. (2017) · Journal of Gynecology & Neonatal Biology · doi:10.15436/2380-5595.17.1607 · Cited by 1
DIAGNOSIS OF ABDOMINAL TRAUMA IN KEMEROVO: 20-YEAR EXPERIENCE
Подолужный, В. И., Ооржак, О. В., & Радионов, И. А. (2017) · Fundamental and Clinical Medicine · doi:10.23946/2500-0764-2017-2-4-22-26 · Cited by 1
A NEW GUIDELINE PROPOSAL FOR PREVENTION OR THERAPY OF PREGNANCY DISORDERS WITH PROGESTOGENS
SCHINDLER, A. E. (2017) · Fundamental and Clinical Medicine · doi:10.23946/2500-0764-2017-2-4-56-61 · Cited by 1
PREGNANCY COURSE AND FETAL CONDITIONS IN WOMEN WITH EXTREMELY PREMATURE BIRTH
Lebedeva, A. V., Zotova, O. A., & Chernyaeva, V. I. (2017) · Fundamental and Clinical Medicine · doi:10.23946/2500-0764-2017-2-4-27-33 · Cited by 1
Perturbation of Endometrial Decidualization
Murakami, K., Kuroda, K., & Brosens, J. J. (2018) · Springer eBooks · doi:10.1007/978-981-10-8690-8_10 · Cited by 3
Zhuk, S. I., Чечуга, С. Б., & Ночвіна, О. А. (2020) · Reproductive Endocrinology · doi:10.18370/2309-4117.2020.54.72-78 · Cited by 3
Lutealphaseninsuffizienz bei Kinderwunsch
Sonntag, B. (2021) · Gynäkologische Endokrinologie · doi:10.1007/s10304-020-00367-2 · Cited by 1
Die Therapie der gestörten Frühschwangerschaft
Maeffert, J., & Tennhardt, C. (2021) · Springer eBooks · doi:10.1007/978-3-662-63517-9_5 · Cited by 1
Chechuha, S. B., Невгадовська, П. М., & Ночвіна, О. А. (2022) · Reproductive Endocrinology · doi:10.18370/2309-4117.2022.65.60-66 · Cited by 1
Dydrogesterone: Shining New Light on Life
Brown, H. (2018) · EMJ Reproductive Health · doi:10.33590/emjreprohealth/10311364 · Cited by 1
Eapen, A. K. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
Self-citationDevall, A., Gallos, I. D., Khalaf, Y., Mol, B. W., Ross, J. A., Shennan, A. H., Horne, A. W., Small, R., Goddijn, M., van Wely, M., et al. (2020) · doi:10.22541/au.159015493.35679779 · Cited by 1
Self-citationProgestogens in threatened miscarriage
Carp, H. (2014) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2013.12.030
Role of Progesterone in Miscarriage
Ray, A. (2016) · International journal of Gynecology Obstetrics and Neonatal Care · doi:10.15379/2408-9761.2016.03.02.02
“Also no significant differences were observed between the treatment and placebo group in terms of: gestational age at delivery, clinical pregnancy (at 6-8 weeks), ongoing pregnancy (at 12 weeks), ectopic pregnancy, miscarriage rates, stillbirths and neonatal outcomes [45].”
BackgroundProgesteron bei habituellen Aborten wirkungslos
Schumacher, B., & Möller, J. (2016) · gynäkologie + geburtshilfe · doi:10.1007/s15013-016-0859-3
Pore, S., Gaidhankar, S. L., Jadhav, S. S., Naik, S. K., & Ramanand, S. J. (2016) · International Journal of Biomedical Research · doi:10.7439/ijbr.v7i7.3391
“multicentre, double blind, placebo-controlled randomized trial involving 1568 women failed to show increased rate of live births with first trimester progesterone therapy in women with history of recurrent miscarriages.[31] In view of current evidence, use of progesterone to prevent miscarriage in”
BackgroundFACULTAD DE CIENCIAS MÉDICAS CARRERA: MEDICINA
Vásquez, D. (2016)
Ae, S. (2016) · Journal of Gynecology Research · doi:10.15744/2454-3284.2.104
“The most recent and largest study with the highest amount of vaginal micronized progesterone revealed the following [2]: Results Micronized progesterone”
BackgroundResultInfluentialProgesterone Use in Early Pregnancy
Harb, H. M., & Coomarasamy, A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781139976787.027 · Cited by 1
Self-citationMaksymovych, N., Zaliska, O., & Mudrak, I. H. (2017) · Фармацевтичний часопис · doi:10.11603/2312-0967.2016.4.7123
Recurrent Pregnancy Loss: Current Evidence and Clinical Guideline
Sugiura‐Ogasawara, M. (2017) · Comprehensive gynecology and obstetrics · doi:10.1007/978-981-10-2489-4_10 · Cited by 2
Евгеньевич, В. И., Ganyukov, V. I., Sizova, I. N., & VERESCHAGIN, E. I. (2017) · Fundamental and Clinical Medicine · doi:10.23946/2500-0764-2017-2-4-79-84 · Cited by 1
Velikanova, E. A., Antonova, L. V., Sevost’yanova, V. V., Kutikhin, A. G., Glushkova, T. V., Матвеева, В. Г., Krivkina, E. O., Барбараш, О. Л., & Barbarash, L. S. (2017) · Fundamental and Clinical Medicine · doi:10.23946/2500-0764-2017-2-4-6-13
Progestogens/hCG Supplementation: A Vital Role?
Singh, N. (2017) · Springer eBooks · doi:10.1007/978-981-10-7338-0_24
Hormones in Recurrent Pregnancy Loss
Agarwal, N., & Kulshrestha, V. (2017) · Springer eBooks · doi:10.1007/978-981-10-7338-0_6
Savelyeva, I. V., Shirokova, O. V., Анатольевна, Б. Е., Polyanskaya, I. B., Георгиевна, Г. Е., Krasnikova, E. P., Гариславович, П. Е., Васильевич, Д. П., Владимировна, Н. Н., Dsubenko, S. S., et al. (2018) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2018-7-60-63
Evidence Based Management in Recurrent Pregnancy Loss
Rashmi, R. (2017) · Springer eBooks · doi:10.1007/978-981-10-7338-0_15
Die Fehlgeburt – Krankheitsprozess oder Schicksalsereignis
Zimmermann, P., Stammer, G., Maris, B., & Mijic, T. (2018) · Der Merkurstab · doi:10.14271/dms-20940-de
Tewary, S., & Brosens, J. J. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108236263.021
A 32-Year-Old Woman with Recurrent Pregnancy Loss
Taubel, D. A. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108227469.057
Redaktsiia (2017) · Russian Journal of Human Reproduction · doi:10.17116/repro201723332-34 · Cited by 1
The importance of progesteron for the safety of pregnancy at early and late terms
Shurpyak, S. О., & Пирогова, В. И. (2019) · Reproductive Endocrinology · doi:10.18370/2309-4117.2019.48.49-54
Nazarenko, L. G., & Бибик, Е. А. (2019) · Reproductive Endocrinology · doi:10.18370/2309-4117.2019.50.22-28
“В стремлении уточнить эффективность прогестагенов путем усовершенствования критериев оценки результатов терапии было инициировано и проведено многоцентровое рандомизированное плацебо-контролируемое исследование PROMISE (Progesterone in Recurrent Miscarriages), в котором в качестве исследуемого препарата использовали м…”
Ist eine Supplementierung sinnvoll oder nicht?
Ludwig, M. Z. (2020) · gynäkologie + geburtshilfe · doi:10.1007/s15013-020-2970-8
Revisión de la utilidad del uso de progesterona en aborto recurrente de causa no precisada
Díaz, P., von Bischhoffshausen, S., Bustos, B. S., Jensen, R., Arraztoa, J. A., & Donoso, M. S. R. (2019) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262019000600526
A Randomized Trial of Progesterone in Women With Bleeding in Early Pregnancy
Coomarasamy, A., Devall, A., Cheed, V., Harb, H. M., Middleton, L. J., Gallos, I. D., Williams, H., Eapen, A. K., Roberts, T. E., Ogwulu, C. O., et al. (2019) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000578752.29446.8d
Self-citationChmaj-Wierzchowska, K., Olejniczak, T., Tuzel, J., Kaczorowska, I., Husam, S., Budna, J., Dera-Szymanowska, A., Olejniczak, K., & Szymanowski, K. (2018) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog4141.2018 · Cited by 2
Clinical and immunological aspects on recurrent pregnancy loss
Bruno, V. (2020) · Linköping University medical dissertations · doi:10.3384/diss.diva-170492
Recurrent Miscarriage (Content last reviewed: 15th March 2020)
Malick, S. M., & Ganapathy, R. (2017)
Abortos espontáneos recurrentes
Merviel, P., Hannigsberg, J., Trémouilhac, C., Herrmann, S., Saliou, A. ‐., Dupré, P., MOREUIL, C. D., Pasquier, É., Moigne, E. L., & Couturaud, F. (2021) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(21)45478-0 · Cited by 1
Progesterone Treatment Does Not Help Recurrent Miscarriage Patients
Coomarasamy, A. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108986373.102
Self-citationProgesterone Treatment Does Not Help Recurrent Miscarriage Patients
Rai, R. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108986373.101
Self-citationPiette, P. C. M. (2021) · Reproductive Endocrinology · doi:10.18370/2309-4117.2021.61.39-44
NICE guideline “Ectopic pregnancy and miscarriage”: new changes and importance for the clinicist
- (2021) · Reproductive Endocrinology · doi:10.18370/2309-4117.2021.62.48-52
Vomstein, K. (2020) · Springer eBooks · doi:10.1007/978-3-662-59809-2_6
Mechanism of LIN28B in trophoblastic villous cells of unexplained recurrent abortionPreprint
Huang, Q., Niu, Y., Song, L.-J., Huang, J., Wang, C., & Ma, T. (2019) · Research Square · doi:10.21203/rs.2.15538/v1
Strowitzki, T. (2016) · Springer eBooks · doi:10.1007/978-3-662-50424-6_14
Norman, J. E. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733249066.793561522
Mechanism of LIN28B in trophoblastic villous cells of unexplained recurrent abortionPreprint
Huang, Q., Niu, Y., Song, L.-J., Huang, J., Wang, C., & Ma, T. (2020) · Research Square · doi:10.21203/rs.2.15538/v3
Beurteilung und Therapie der Lutealphase
Sonntag, B. (2018) · Springer eBooks · doi:10.1007/978-3-662-55601-6_8-1
Experience of Application of Micronized Progesterone in the Prevention of Reproductive Losses
Лебедюк, В. В. (2020) · Репродуктивное здоровье Восточная Европа · doi:10.34883/pi.2020.10.2.008
Ainsworth, S. B. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780198840787.003.0028
Mechanism of LIN28B in trophoblastic villous cells of unexplained recurrent abortionPreprint
Huang, Q., Niu, Y., Song, L.-J., Huang, J., Wang, C., & Ma, T. (2020) · Research Square · doi:10.21203/rs.2.15538/v2
Abort und rezidivierendes Abortgeschehen
Rogenhofer, N., Buchholz, T., & Thaler, C. (2021) · Elsevier eBooks · doi:10.1016/b978-3-437-23753-9.00010-4
Rola waspiny w regulacji fizjologii i patologii komórek jajnika
Kurowska, P., Mlyczyńska, E., Pich, K., Dawid, M., Respekta, N., & Rak, A. (2022) · Kosmos · doi:10.36921/kos.2022_2848
Recurrent Pregnancy Loss: reviewing therapeutic approaches
de Oliveira, E. C. F., Praça, M. S. L., Garcia, G. M. P., & Cavallo, I. K. D. (2022) · Human Reproduction Archives · doi:10.4322/hra.000721
CHECK, J. H., & DiAntonio, A. (2022) · Gynecology & Reproductive Health · doi:10.33425/2639-9342.1180
İbanoğlu, M. C., Köse, C., Tatlıcı, T. K., Erdoğan, K., Karadeniz, S., Erkaya, S., & Üstün, Y. E. (2023) · Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi · doi:10.47572/muskutd.1095993
Mifepristone Antagonization with Progesterone to Avert Medication Abortion: A Scoping Review
DeBeasi, P. L. C. (2023) · The Linacre Quarterly · doi:10.1177/00243639231176592
“It promotes placental development, prepares the uterus for embryo implantation (Coomarasamy et al. 2015, 2142), and inhibits uterine contractions (Scarpin et al. 2009, 1).”
BackgroundAmrani, M. (2023) · Springer eBooks · doi:10.1007/978-3-662-65371-5_7
Schenone, C. V., & Ros, S. T. (2023) · Wiley eBooks · doi:10.1002/9781119636540.ch32
Ejaz, S., Raana, M., Essa, M., Zahra, S., Ishaq, S., Shoaib, U., Irshad, M., & Abideen, Z. U. (2024) · BioSight · doi:10.46568/bios.v5i1.171
“Results showed positive role of progesterone in reducing the risk of further miscarriages but no significant reduction in the occurrence of preterm birth[21].”
BackgroundReview Article: Early Recurrent Pregnancy Loss
Suhail, H. A. (2024) · Journal for Research in Applied Sciences and Biotechnology · doi:10.55544/jrasb.3.1.51
Wu, H., Zhang, S., Lin, X., He, J., Wang, S., & Zhou, P. (2021) · Figshare · doi:10.6084/m9.figshare.16928192
Wu, H., Zhang, S., Lin, X., He, J., Wang, S., & Zhou, P. (2021) · Figshare · doi:10.6084/m9.figshare.16928189
Sun, B., Li, L., Chen, X., & Sun, Y. (2023) · Figshare · doi:10.6084/m9.figshare.22800040
Twin-Reversed Arterial Perfusion (TRAP) Sequence: Case Report and Literature Review
Wajih, O., Benfdil, L., Elomri, H., Bouyalik, F., Jalal, M., Lamrissi, A., & Bouhya, S. (2024) · Gynecology & Reproductive Health · doi:10.33425/2639-9342.1249
Supporting Maternal Autonomy in Medical Abortion Pathways
Turner, J., & Chaku, J. D. (2024) · Integrated science · doi:10.1007/978-3-031-64292-0_18
Gestational Inflammation: Its Foetal Control and the Proper Therapeutic ApproachPreprint
Vesce, F. (2025) · Qeios · doi:10.32388/dmytgw.2
Gestational Inflammation: Its Foetal Control and the Proper Therapeutic ApproachPreprint
Vesce, F. (2025) · Qeios · doi:10.32388/dmytgw.3
Pregnancy Loss: From Cytogenetics to Genomics
Tise, C. G., Verma, K., & Lathi, R. B. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009532549.029
Progesterone Use in Early Pregnancy
Harb, H. M., & Coomarasamy, A. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009532549.030
Self-citationGuidelines on the Diagnosis and Management of Sporadic Miscarriage
Oliver, A., & Overton, C. E. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009532549.015
Ma, H., Wang, Y., Gao, J., Zhu, M., Zhang, Y., Liu, Y., Ng, E. H. Y., Wang, C. C., Mol, B. W., & Wu, X. (2025) · Evidence-Based Chinese Medicine and Technology Assessment · doi:10.26599/ecmta.2025.9570009
Self-citationProgesterone therapy and clinical outcome in recurrent pregnancy loss patients
Bhat, A., Mittu, B., Singh, M., Singla, R., Chaturvedi, A., & Sharma, N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13657-3.00011-8
Abort und rezidivierendes Abortgeschehen
Rogenhofer, N., Buchholz, T., & Thaler, C. (2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21097-6.00010-x
Progesterone therapy in the prevention of pregnancy loss
Altaiam, A., & Almomani, J. R. (2025) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20253284
Davydova, A. A., Mikhailova, V. A., Chepanov, S. V., Zementova, M. S., Ивановна, А. Е., Владимировна, М. Е., Shengelia, M. O., Olina, A. A., Yarmolinskaya, M. I., Bespalova, O. N., et al. (2025) · Journal of obstetrics and women s diseases · doi:10.17816/jowd683668
Wu, J., Yin, L., Deng, X., Ji, C., Dong, J., & Xiao, X. (2025) · European journal of medical research · doi:10.1186/s40001-025-03370-0
“The use of progesterone in women to prevent miscarriage remains controversial [5, 6, 26, 27] and warrants a balance of benefits and harms.”
Ligne directrice n° 464 : Fausses couches à répétition
Motan, T., Cockwell, H., Elliott, J., Antaki, R., & White, J. S. (2025) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2025.103168
Zhong, C., Xiong, G., Lin, L., Li, Q., Chen, X., Zhang, X., Zhang, Y., Xu, S., Wang, X., Gao, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19720003
Youssef, A., Lashley, E. E. L. O., Vermeulen, N., & van der Hoorn, M. L. P. (2023) · Figshare · doi:10.6084/m9.figshare.23803187
Wu, H., Zhang, S., Lin, X., He, J., Wang, S., & Zhou, P. (2021) · Figshare · doi:10.6084/m9.figshare.16928195
Kim, I., Bae, S., Han, H., & Na, S. (2025) · Perinatology · doi:10.14734/pn.2025.36.4.91
Hansu, K., Özer, A., & Bakkaloğlu, İ. (2026) · Anatolian journal of obstetrics and gynecology research. · doi:10.4274/anajog.galenos.2025.07279
Miscarriages: Epidemiology, diagnosis, and management
MEKINIAN, A., & Abisror, N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00357-5
Jia, X., Wei, L., Zheng, B.-L., Liu, E., Li-na, G., & Zhang, N. (2026) · Open Medicine · doi:10.1515/med-2025-1370
Efficacy of Oral Progesterone Treatment in Women with Unexplained Recurrent First Miscarriages
Aziz, M. U. A., & Zainab, S. (2026) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v7i3.3565
Optimization of conception with intercourse for women with infertility
Boedeker, D., Neumann, B., Vest, A. N., Hill, M. J., Stanford, J. B., & Johnstone, E. B. (2026) · Fertility and Sterility · doi:10.1016/j.fertnstert.2026.04.002
Perda gestacional de repetição e o papel dos progestagênios: evidências atuais
de Oliveira, E. C. F., Queiroz, B. C., & Cruzeiro, I. K. D. C. (2023) · Femina · doi:10.61622/0100-7254511202308
Pasquier, É., Martin, L. D. S., Marhic, G., Gal, G. L., Delluc, A., Pimentel, C., MEKINIAN, A., Chauleur, C., Plu‐Bureau, G., Bohec, C., et al. (2026) · The Lancet Obstetrics Gynaecology & Women s Health · doi:10.1016/s3050-5038(25)00207-9 · Cited by 2
Silva-Edge, M., Elfituri, A., & Shehata, H. A. (2026) · Springer eBooks · doi:10.1007/978-3-032-23479-7_2
Metadata
- Authors
- Coomarasamy, A., Williams, H., Truchanowicz, E., Seed, P. T., Small, R., Quenby, S., Gupta, P., Dawood, F., Koot, Y. E. M., Bender Atik, R., Bloemenkamp, K. W. M., Brady, R., Briley, A. L., Cavallaro, R., Cheong, Y. C., Chu, J. J., Eapen, A., Ewies, A., Hoek, A., Kaaijk, E. M., Koks, C. A. M., Li, T.-C., MacLean, M., Mol, B. W., Moore, J., Ross, J. A., Sharpe, L., Stewart, J., Vaithilingam, N., Farquharson, R. G., Kilby, M. D., Khalaf, Y., Goddijn, M., Regan, L., & Rai, R.
- Affiliations
- St Thomas' Hospital (GB)
- University of Birmingham (GB)
- Heart of England NHS Foundation Trust (GB)
- University of Warwick (GB)
- Liverpool Womens NHS Foundation Trust (GB)
- University Medical Center Utrecht (NL)
- Leiden University Medical Center (NL)
- Imperial College London (GB)
- Princess Anne Hospital (GB)
- Sandwell & West Birmingham Hospitals NHS Trust (GB)
- University of Groningen (NL)
- OLVG (NL)
- Máxima Medisch Centrum (NL)
- Royal Hallamshire Hospital (GB)
- University Hospital Crosshouse (GB)
- The University of Adelaide (AU)
- Nottingham University Hospitals NHS Trust (GB)
- King's College Hospital NHS Foundation Trust (GB)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Portsmouth Hospitals NHS Trust (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-11-26
- Volume
- 373
- Issue
- 22
- Pages
- 2141-2148
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2236902456
- Cited by
- 312
- References
- 22
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 24 · 2023: 24 · 2022: 22 · 2021: 33 · 2020: 35 · 2019: 28 · 2018: 38 · 2017: 36 · 2016: 30 · 2015: 1
- FWCI
- 17.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- University of Birmingham Research Portal (University of Birmingham) (acceptedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research (08/38/01)
- Medical Research Council
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- progesterone supplementation, recurrent pregnancy loss, unexplained recurrent spontaneous abortion, first trimester, live birth rate, micronized progesterone, miscarriage, neonatal survival
- MeSH terms
- Abortion, Habitual, Administration, Intravaginal, Adult, Double-Blind Method, Female, Gestational Age, Humans, Pregnancy, Pregnancy Trimester, First, Progesterone, Body Mass Index, Treatment Failure, Live Birth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.